Could mailing HPV tests boost screening rates?
NCT ID NCT07273383
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether offering HPV self-sampling kits by mail, pharmacy, or clinic can make cervical cancer screening easier. One thousand women aged 25-65 in Quebec will try different ways to get and return the kit. The goal is to see which method works best and if women find it acceptable.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- HPV self-sampling test
- What this could lead to
- If successful, this could make cervical cancer screening easier and more accessible, especially for those without a family doctor.
- What could go wrong
- This is a feasibility study, not a treatment trial. It may not prove that self-sampling is as accurate as clinician-collected samples, and results may not apply outside Quebec.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHUS
Sherbrooke, Quebec, J1H5N3, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could Self-Sampling revolutionize cervical cancer screening?
- Texting parents could be key to curbing HPV-Related cancers
- Pocket-sized HIV test could bring same-day diagnosis to community clinics
- Can anal cancer treatment spare sexual well-being? a study tracks the toll over two years.
- Could a condensed radiation course after cervical cancer surgery be just as safe and effective?
- Simple blood test could spot returning throat cancer sooner